Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 May 2020

Dear Health Sciences applicant
 
At the University of the Free State (UFS), we understand that the current COVID-19 situation is raising many questions for a matriculant who wishes to apply for university study in 2021. We acknowledge the concerns you may have and would like to share important information that should put your mind at ease:
 
1.     The due date for applying to the Faculty of Health Sciences remains 31 May 2020.
 
2.     The following will not be a requirement when applying to study at the UFS in 2021:
 
-          NBT test results
-          Grade 12 June examination results
 
3.     The following is required for application to study at the UFS in 2021 and must accompany your application for admission:
 
-          Grade 11 final examination results  
 
4.     The following supporting documents that you are required to submit together with your application, may be forwarded to FHSApplications@ufs.ac.za at a later stage when the lockdown level makes it possible for you to have these forms completed:
 
-          The school value-added form
-          Confirmation of good health by a medical practitioner
-          Only in the case of applying for Occupational Therapy selection: a motivation (no more than 250 words) can be submitted instead of the proof of a visit to an occupational therapy practice.
 
Therefore, we urge you to apply as soon as possible before the deadline and then send the outstanding documents at a later stage.
 
We look forward to receiving your application to study at Kovsies in 2021!

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept